ClinicalTrials.Veeva

Menu

Socket Preservation Using Biodentin Versus Xeno Graft for Single Rooted Teeth

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Enrolling
Phase 4

Conditions

Socket Perservation

Treatments

Drug: Biodentine

Study type

Interventional

Funder types

Other

Identifiers

NCT06695208
CEBD_CU_2024-01-26

Details and patient eligibility

About

socket preservation using biodentin versus xeno graft for single rooted mandibular teeth

Full description

after extraction of single rooted mandibular teeth the socket will be filled with xeno graft or biodentine and the socket will be closed using gel foam and sutures then CBCT will be taken to measure bone width after 6 months of healing CBCT will be taken again to measure the difference in bone width and a core biopsy will be taken followed by implant placement

Enrollment

11 estimated patients

Sex

All

Ages

25 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients of both sex with badly decayed tooth indicated for extraction
  • The ages of the patients ranged from 25 to 50 years.
  • Patients with healthy systemic condition (Medically free)
  • Adequate inter-arch space for placement of the implant prosthetic part.
  • Good oral hygiene
  • Cooperative patients who are willing to commit for 6 months follow up

Exclusion criteria

  • Subjected to irradiation in the head and neck area less than 1 year before implantation.
  • Poor oral hygiene and motivation.
  • Smokers
  • Patient with medical condition that contraindicates surgical procedures
  • Pregnant or nursing.
  • Substance abuse.
  • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or parafunctional habits severe bruxism or clenching.
  • Active infection or severe inflammation in the area intended for implant placement.
  • Patients on medication that may interfere with healing (corticosteroids, bisphosphonate, Chemo/radio therapy).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

11 participants in 2 patient groups

biodentine group
Experimental group
Treatment:
Drug: Biodentine
xeno graft group
Active Comparator group
Treatment:
Drug: Biodentine

Trial contacts and locations

1

Loading...

Central trial contact

maxim gerges, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems